ATHN 11: Liver Transplantation Outcomes Study

ATHNdataset Registry

NCT06820515 ·Status: RECRUITING

Data Registry in Chinese Hemophilia A and B Patients

NCT07101224 ·Status: COMPLETED

The Second Multicenter Hemophilia Cohort Study

NCT00341705 ·Status: COMPLETED

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

NCT03876301 ·Status: COMPLETED

Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

NCT01125813 ·Status: COMPLETED ·Phase: PHASE3

Epidemiology and Immunology of Hemophilia A Inhibitors

NCT00005518 ·Status: COMPLETED

Learning to Live With Non-severe Haemophilia

NCT05314751 ·Status: COMPLETED

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

NCT04370054 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

2-cohort Study of Adult Patients With Severe Hemophilia A in Greece

NCT02319070 ·Status: COMPLETED

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A

NCT00989196 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719 ·Status: RECRUITING ·Phase: PHASE3

LTFU for Gene Transfer Subjects With Hemophilia B

NCT00515710 ·Status: COMPLETED

A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care

NCT02049099 ·Status: COMPLETED

PF-06741086 Multiple Dose Study in Severe Hemophilia

NCT02974855 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

NCT03587116 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

NCT05911763 ·Status: ACTIVE_NOT_RECRUITING

Dosage and PD Study of Eftrenonacog-alfa

NCT04590950 ·Status: COMPLETED

Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A

NCT04418414 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study to Evaluate Seroprevalence and Seroconversion of Antibodies to Adeno-Associated Virus (AAV) in Patients With Hemophilia A

NCT04560933 ·Status: COMPLETED

A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM

NCT05695391 ·Status: TERMINATED ·Phase: PHASE3

A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

NCT02035605 ·Status: COMPLETED ·Phase: PHASE1

PF-06741086 Long-term Treatment in Severe Hemophilia

NCT03363321 ·Status: COMPLETED ·Phase: PHASE2

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT04398628 ·Status: RECRUITING

Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies

NCT03103542 ·Status: COMPLETED ·Phase: PHASE4